Please assess the completion status of the following clinical trial:

Trial Title: Preventing Hypotension in Parturients With an Elevated Body Mass Index (BMI)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* English speaking~* ASA Physical Status I-II~* Non-laboring women~* Single gestations ≥ 36 weeks~* Obese women (Body Mass Index 35 - 55 kg/m2)~* Non-emergent CD under spinal anesthesia~Exclusion Criteria:~* Height \< 5'0~* Antiemetic drug use in the 24 hours prior to CD~* Allergy to phenylephrine, or any other standardized medication~* Hypertensive disease of pregnancy (i.e. mild \& severe preeclampsia)~* Chronic hypertension receiving antihypertensive treatment~* Severe Cardiac disease in pregnancy with marked functional limitations~* Patients on Monoamine Oxidase Inhibitors or Tricyclic Antidepressants~* Subject enrollment in another study involving a study medication within 30 days of CD~* Any other physical or psychiatric condition which may impair their ability to cooperate with study data collection

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Phenylephrine bolus (Type: EXPERIMENTAL): None
- Phenylephrine infusion (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).